홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CNTA
#1177
Centessa Pharmaceuticals plc American Depositary Shares
39.590
0
USD
+0.05%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.05%
월간 변동
+49.45%
6달 변화
+61.46%
년간 변동율
+61.46%
이전 종가
39.570
0
Open
39.590
0
Bid
Ask
Low
39.590
0
High
39.590
0
양
24
마켓
주식
헬스케어
CNTA
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
94.02 M
94.96 M
100.31 M
133.18 M
154.57 M
—
Valuation ratios
Enterprise value
539.28 M
-26.62 M
762.52 M
1.97 B
3.92 B
11.02 B
Price to earnings ratio
—
-1.35
-5.11
-8.13
-17.13
-44.61
Price to sales ratio
—
-104.41
112.7
—
226.28
682.92
Price to cash flow ratio
—
-1.46
-4.82
-13.5
-17.51
-56.7
Price to book ratio
—
0.87
3.27
4.78
6.44
10.67
EBITDA 비율에 대한 기업 가치
—
1.67
-14.7
-22
-110.12
-307.66
Profitability ratios
Return on assets %
-0
-0.49
-0.42
-0.41
-0.29
-0.37
Return on equity %
-0
-0.64
-0.64
-0.59
-0.37
-0.52
Return on invested capital %
-426.46
-7 600.19
-1 532.77
-1 554.98
-429.59
-419.44
Gross margin %
—
100
100
—
100
—
Operating margin %
—
7 580.82
-2 499.39
—
-1 384.61
—
EBITDA margin %
—
2 066.75
-672.23
—
-230.31
—
Net margin %
—
7 721.68
-2 204.65
—
-1 316.88
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
25.52
11.42
8
9.25
8.57
43.62
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
-0.01
0.02
0
0.02
0.03
Solvency ratios
Debt to assets ratio
0.12
0.16
0.24
0.2
0.17
0.9
Debt to equity ratio
0.15
0.21
0.36
0.29
0.22
1.26
Long term debt to total assets ratio
0.12
0.16
0.21
0.19
0.16
0.83
Long term debt to total equity ratio
0.15
0.21
0.32
0.27
0.21
1.17
Per share metrics
Operating cash flow per share
—
-2.15
-1.67
-1.24
-1.43
-1.44
EBIT per share
—
-0.62
-0.49
-0.74
-0.26
-0.26
EBITDA per share
—
-0.62
-0.48
-0.73
-0.25
-0.26
Total debt per share
—
0.75
0.88
1.03
0.87
3.52
Cash per share
—
4.21
2.67
4.21
2.17
8.02
Net current asset value per share
—
4.69
3.28
4.69
2.71
9.86
Tangible book value per share
—
3.6
2.46
3.51
3.88
11.61
Working capital per share
—
4.28
2.87
4.18
2.39
8.93
Book value per share
—
3.6
2.46
3.51
3.88
11.61
뉴스
Biotech Is Holding Steady In 2026 (NASDAQ:IBB)
LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal
Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket
Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug
울프 리서치, 센테사 주식에 대해 시장수익률 상회 등급으로 시작
Wolfe Research initiates Centessa stock with outperform rating
파이퍼 샌들러, 센테사 주식에 ’비중확대’ 의견 재확인
Piper Sandler reiterates Overweight rating on Centessa stock ahead of catalysts
센테사, 동물 실험서 OX2R 작용제의 항우울 효과 보고
Centessa reports antidepressive effects of OX2R agonist in animal study
센테사 제약, 주가 하락은 매수 기회 - TD Cowen
Centessa Pharmaceuticals stock pullback offers good entry point, says TD Cowen